Jim Cramer discusses not discussing the 'market' and also suggests a Darth Vader-Amazon meeting.
The Merck collab would count as Leap's first of planned studies with immunotherapies, but the collaboration is not Keytruda's first rodeo.
Here are the names.
It just isn't as useful or descriptive right now.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.